The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair
Open accessAbstract
Fanconi anemia (FA) is a recessive disorder characterized by congenital abnormalities, progressive bone-marrow failure, and cancer susceptibility. Cells from FA patients are hypersensitive to agents that produce DNA crosslinks and, after treatment with these agents, have pronounced chromosome breakage and other cytogenetic abnormalities. Eight FANC genes have been cloned, and the encoded proteins interact in a common cellular pathway. DNA-damaging agents activate the monoubiquitination of FANCD2, resulting in its targeting to nuclear foci that also contain BRCA1 and BRCA2/FANCD1, proteins involved in homology-directed DNA repair. Given the interaction of the FANC proteins with BRCA1 and BRCA2, we tested whether cells from FA patients (groups A, G, and D2) and mouse Fanca –/– cells with a targeted mutation are impaired for this repair pathway. We find that both the upstream (FANCA and FANCG) and downstream (FANCD2) FA pathway components promote homology-directed repair of chromosomal double-strand breaks (DSBs). The FANCD2 monoubiquitination site is critical for normal levels of repair, whereas the ATM phosphorylation site is not. The defect in these cells, however, is mild, differentiating them from BRCA1 and BRCA2 mutant cells. Surprisingly, we provide evidence that these proteins, like BRCA1 but unlike BRCA2, promote a second DSB repair pathway involving homology, i.e., single-strand annealing. These results suggest an early role for the FANC proteins in homologous DSB repair pathway choice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The DR-U2OS cell line containing a single integrated copy of the DR-GFP reporter was used46,47.”
From BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing (2017) · cites this paper as [46]
Citations
Cites
XRCC3 promotes homology-directed repair of DNA damage in mammalian cellsPreprint
Pierce, A. J., Johnson, R. D., Thompson, L. H., & Jasin, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2633 · Cited by 1,384
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Self-citationInteraction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Self-citationBiallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
Self-citationBRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,007
Self-citationMolecular views of recombination proteins and their control
West, S. C. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1127 · Cited by 977
The Fanconi anaemia/BRCA pathway
D'Andrea, A. D., & Grompe, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc970 · Cited by 822
Self-citationLee, S. E., Moore, J. K., Holmes, A. M., Umezu, K., Kolodner, R. D., & Haber, J. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81482-8 · Cited by 784
BRCA2 Function in DNA Binding and Recombination from a BRCA2-DSS1-ssDNA Structure
Yang, H., Jeffrey, P. D., Miller, J. J., Kinnucan, E., Sun, Y., Thomä, N. H., Zheng, N., Chen, P., Lee, W., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.297.5588.1837 · Cited by 719
Homology-directed repair is a major double-strand break repair pathway in mammalian cells
Liang, F., Han, M., Romanienko, P. J., & Jasin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5172 · Cited by 649
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Moynahan, M. E., Cui, T. Y. & Jasin, M. (2001) Cancer Res. 61, 4842–4850.11406561
- McAllister, K. A., Bennett, L. M., Houle, C. D., Ward, T., Malphurs, J., Collins, N. K., Cachafeiro, C., Haseman, J., Goulding, E. H., Bunch, D., et al. (2002) Cancer Res. 62, 990–994.11861370
Cited by
Sorted by citations
Items 201–300 of 385
The Fanconi anemia pathway in replication stress and DNA crosslink repair
Jones, M. V., & Huang, T. T. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1051-0 · Cited by 33
“Deficiency in either the FA core or ID complexes in this assay leads to a relatively mild HR defect compared to downstream FA pathway components, such as BRCA2 [77, 82].”
InfluentialMuñoz, M. C., Yanez, D. A., & Stark, J. M. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku421 · Cited by 34
“FANCD2 is part of the Fanconi Anemia pathway that is important for DNA crosslink repair and HR (45,46).”
BackgroundInherited bone marrow failure syndromes in 2012
Sakaguchi, H., Nakanishi, K., & Kojima, S. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1249-9 · Cited by 32
“In 2005, a cellular study in humans showed that mutation of either the FA core complex members or the FANCD2 monoubiquitination site resulted in HR defects [16].”
BackgroundSelf-citationShao, X., Joergensen, A. M., Howlett, N. G., Lisby, M., & Oestergaard, V. H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa268 · Cited by 36
“Notably, FANCA-disrupted One role of BRCA2, BLM and FANCD2 at T–”
van de Kooij, B., van der Wal, F. J., Rother, M. B., Wiegant, W. W., Creixell, P., Stout, M., Joughin, B. A., Vornberger, J., Altmeyer, M., van Vugt, M. A. T. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51090-6 · Cited by 31
“Thus, both FANCL and Ube2T are recruited to UV-A laser-induced DSBs. FANCD2 has previously been shown to accumulate at DNA damage sites upon DSB-inducing treatments 43,44 .”
InfluentialDefects in homologous recombination repair behind the human diseases: FA and HBOC
Katsuki, Y., & Takata, M. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0221 · Cited by 32
“2003, 2004) or mildly decreased in human cells (Nakanishi et al. 2005).”
Selemenakis, P., Sharma, N., Uhrig, M. E., Katz, J., Kwon, Y., Sung, P., & Wiese, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.866601 · Cited by 29
“We used U2OS-DRGFP cells (Nakanishi et al., 2005; Xia et al., 2006) to assess the effects of RAD51AP1 and/or RAD54L depletion on gene conversion.”
Fiesco-Roa, M. Ó., Teresa, B. G., Leal-Anaya, P., Hek, R. V., Wegman-Ostrosky, T., Frı́as, S., & Rodríguez, A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.949435 · Cited by 34
“Ub-FANCD2I is being long recognized as essential for the recruitment of proteins involved in the DNA repair downstream activities of the FA/ BRCA pathway (21), as FANCD2-I forms nuclear DNA repair foci co-localize with DNA repair factors (22).”
BackgroundKarttunen, H., Savas, J. N., McKinney, C. C., Chen, Y.-H., Yates, J. R., Hukkanen, V., Huang, T. T., & Mohr, I. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.020 · Cited by 30
“Intriguingly, FANCD2 (and likely FANCI) monoubiquitination is required for SSA, suggesting an early role for monoubiquitinated FA effector proteins in homologous DSB repair pathway choice (Nakanishi et al., 2005).”
Human Mus81 and FANCB independently contribute to repair of DNA damage during replication
Nomura, Y., Adachi, N., & Koyama, H. (2007) · Genes to Cells · doi:10.1111/j.1365-2443.2007.01124.x · Cited by 28
UBE2W Interacts with FANCL and Regulates the Monoubiquitination of Fanconi Anemia Protein FANCD2
Zhang, Y., Zhou, X., Zhao, L., Li, C., Zhu, H.-Q., Xu, L., Shan, L., Liao, X., Guo, Z., & Huang, P. (2011) · Molecules and Cells · doi:10.1007/s10059-011-0015-9 · Cited by 28
“For example, cells use homologous DNA repairs (HDR) to eliminate DNA cross-linking damages (Nakanishi et al., 2005) but use excision repair to eliminate CPDs (de Lima-Bessa et al.”
BackgroundOuyang, Y., Kwon, Y. T., An, J. Y., Eller, D., Tsai, S.-C., Diaz-Perez, S. V., Troke, J. J., Teitell, M. A., & Marahrens, Y. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.12.016 · Cited by 28
The nuclear accumulation of the Fanconi anemia protein FANCE depends on FANCC
Léveillé, F., Ferrer, M., Medhurst, A. L., Laghmani, E. H., Rooimans, M. A., Bier, P., Steltenpool, J., Titus, T. A., Postlethwait, J. H., Hoatlin, M. E., et al. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.01.005 · Cited by 28
Truong, L. N., Li, Y., Sun, E., Ang, K., Hwang, P. Y.-H., & Wu, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576488 · Cited by 29
“Expressing shRNAs for fanconi anemia (FA) proteins FancA and FancD2, which are important for HR (45), also decreased HR-mediated DSB repair at SC-HR-EGFP-SV40 ori upon SV40 T expression (Fig.”
BackgroundSnm1B/Apollo functions in the Fanconi anemia pathway in response to DNA interstrand crosslinks
Mason, J. M., & Sekiguchi, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr153 · Cited by 25
“FANCD2 depletion reduced the frequency of homologous recombination by 50%; however, the defect was less severe compared with RAD51-depleted cells, as previously reported (6,13,42,49).”
BackgroundResultO’Connell, M. J. (2010) · Journal of Molecular Evolution · doi:10.1007/s00239-010-9399-y · Cited by 25
Eccles, L. J., Bell, A., & Powell, S. N. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.02.003 · Cited by 25
Molecular Pathogenesis of Fanconi Anemia
Collins, N. B., & Kupfer, G. M. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05108 · Cited by 26
“In a similar assay monitoring the HDR of an I-SceI DSB, patient-derived cells from groups FA-A, FA-G, and FA-D2, as well as cells from mice homozygous for FANCA deletion, were shown to be defective in HDR [ 64 ,65].”
Background3R coordination by Fanconi anemia proteins
Macé‐Aimé, G., Bogliolo, M., Guervilly, J.-H., du Villard, J.-A. D., & Rosselli, F. (2005) · Biochimie · doi:10.1016/j.biochi.2005.05.003 · Cited by 26
Alagpulinsa, D. A., Yaccoby, S., Ayyadevara, S., & Reis, R. J. S. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1040951 · Cited by 26
“Also, the drug induced cell-cycle arrest during S phase, a key interval during which the FA pathway interacts with BRCA1 and RAD51 to activate RAD51-mediated repair of ICLs.9,37 BRCA1 and paralogs of RAD51 play critical roles in www.tandfonline.com 981Cancer Biology & Therapy the recruitment of RAD51 protein to damage…”
BackgroundInfluentialCTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI
Hu, W.-F., Krieger, K. L., Lagundžin, D., Li, X., Cheung, R. S., Taniguchi, T., Johnson, K. R., Bessho, T., Monteiro, Á. N. A., & Woods, N. T. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0185-3 · Cited by 26
Self-citationFANCD2 influences replication fork processes and genome stability in response to clustered DSBs
Zhu, J., Su, F., Mukherjee, S., Mori, E., Hu, B., & Asaithamby, A. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1036210 · Cited by 25
“Mechanistically, FANCD2 is required for correct recruitment of RPA2 and Rad51 to the sites of clustered DSBs and that is critical for proper processing of clustered DSBs. Significantly, FANCD2-decifient cells exhibited defective chromosome segregation, elevated levels of chromosomal aberrations, and anchorage-independ…”
BackgroundInfluentialZhu, B., Yan, K., Li, L., Lin, M., Zhang, S., He, Q., Zheng, D., Yang, H., & Shao, G. (2014) · Oncogene · doi:10.1038/onc.2014.229 · Cited by 25
Biomarkers and Mechanisms of FANCD2 Function
Willers, H., Kachnic, L. A., Luo, C., Li, L., Purschke, M., Borgmann, K., Held, K. D., & Powell, S. N. (2008) · BioMed Research International · doi:10.1155/2008/821529 · Cited by 24
“Disruption of the nuclear core complex or mutation of FANCD2’s monoubiquitination site at K561 impairs repair processes, including homologous recombination, that are active at stalled forks [8, 14].”
BackgroundTACC3 deregulates the DNA damage response and confers sensitivity to radiation and PARP inhibition
Ha, G., Kim, J.-L., Petersson, A., Oh, S. H., Denning, M. F., Patel, T., & Breuer, E.-K. (2014) · Oncogene · doi:10.1038/onc.2014.105 · Cited by 24
Bi, J., Areecheewakul, S., Li, Y., Yang, S., Zhang, Y., Ebeid, K., Li, L., Thiel, K. W., Zhang, J., Dai, D. D., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.08.014 · Cited by 24
“The FA pathway plays a critical role in DNA repair following interstrand crosslink damage induced by platinum compounds[10].”
BackgroundRemoval of TREX1 activity enhances CRISPR–Cas9-mediated homologous recombination
Karasu, M. E., Toufektchan, E., Chen, Y., Albertelli, A., Cullot, G., Maciejowski, J., & Corn, J. E. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02356-3 · Cited by 27
“For example, loss of function in one of 22 genes involved in Fanconi anemia (FA) can largely prevent HDR 9,12,13 .”
Genomic Instability in Mice Is Greater in Fanconi Anemia Caused by Deficiency of Fancd2 than Fancg
Reliene, R., Yamamoto, M. L., Rao, P. N., & Schiestl, R. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1022 · Cited by 24
Dynamin impacts homology-directed repair and breast cancer response to chemotherapy
Chernikova, S. B., Nguyen, R. B., Truong, J. T., Mello, S. S., Stafford, J. H., Hay, M. P., Olson, A., Solow-Cordero, D. E., Wood, D., Henry, A. S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci87191 · Cited by 24
Hinz, J. M., Nham, P. B., Urbin, S. S., Jones, I. M., & Thompson, L. H. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm315 · Cited by 25
“For example, studies based on chromosomally integrated reporter constructs containing a I–Sce-I restriction site and PCR analysis found no reduction in NHEJ activity in FA cells from three complementation groups (A, D2 and G) compared to gene-complemented control cells (26).”
Diagnosis of Fanconi Anaemia by ionising radiation- or mitomycin C-induced micronuclei
Francies, F. Z., Wainwright, R., Poole, J., Leeneer, K. D., Coene, I., Wieme, G., Poirel, H. A., Brichard, B., Vermeulen, S., Vral, A., et al. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.11.001 · Cited by 22
Nishihori, T., Alekshun, T. J., Shain, K. H., Sullivan, D. M., Baz, R., Perez, L. E., Pidala, J., Kharfan‐Dabaja, M. A., Ochoa-Bayona, J. L., Fernandez, H. F., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09099.x · Cited by 22
Chromosomal Integrity after UV Irradiation Requires FANCD2-Mediated Repair of Double Strand Breaks
Federico, M. B., Vallerga, M. B., Radl, A., Paviolo, N. S., Bocco, J. L., Giorgio, M. D., Soria, G., & Gottifredi, V. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005792 · Cited by 25
“ICLs [12,14,16,81], our report demonstrates that replication-coupled DSBs unrelated to ICLs may require FANCD2 for their repair through the HRR pathway.”
BackgroundEAF2 regulates DNA repair through Ku70/Ku80 in the prostate
Ai, J., Pascal, L. E., Wei, L., Zang, Y., Zhou, Y., Yu, X., Gong, Y., Nakajima, S., Nelson, J. B., Levine, A. S., et al. (2016) · Oncogene · doi:10.1038/onc.2016.373 · Cited by 23
“Using the Hela pDR-GFP-based assay for HR repair 29 , no significant difference was detected in the percentage of GFP-positive cells between siEAF1-treated and siRNA control groups (Figure 4B), indicating that EAF1 may not affect the HR repair pathway.”
Self-citationRegulation of various DNA repair pathways by E3 ubiquitin ligases
Natarajan, C., & Takeda, K. (2017) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.204879 · Cited by 25
Fierheller, C. T., Guitton-Sert, L., Alenezi, W. M., Revil, T., Oros, K. K., Gao, Y., Bédard, K., Arcand, S. L., Serruya, C., Behl, S., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00998-5 · Cited by 22
Liu, B., Liu, M., Wang, J., Zhang, X., Wang, X., Wang, P., Wang, H., Li, W., & Wang, Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1368 · Cited by 22
“Cell HRR reporter assay (29) or NHEJ reporter assay (30) were used as described previously.”
BackgroundMethodRetractedHuang, Y.-L., Chou, W., Hsiung, C.-N., Hu, L., Chu, H., & Shen, C. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv102 · Cited by 21
“For the HRR assay (23,45), in brief, U2OS-DR-GFP cells were cotransfected with pSce (2 μg) and the gene-expressing plasmids (4 μg of an individual plasmid in a 60-mm tissue culture dish) or siRNA indicated in each figures (empty vector or scrambled siRNA as control).”
Bosch, P. C., Bogliolo, M., & Surrallés, J. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.02.007 · Cited by 22
Dail, M. B., Shack, L. A., Chambers, J. E., & Burgess, S. C. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn198 · Cited by 22
The Fanconi anemia protein interaction network: Casting a wide net
Rego, M. A., Kolling, F. W., & Howlett, N. G. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.018 · Cited by 22
“Surprisingly, despite the established interaction between FANCD2 and BRCA1 [36], and BRCA1s important role in the repair of DNA DSBs by HR [51], the ATM-dependent phosphorylation of FANCD2 on S222 does not appear to be required for DNA DSB HR [56].”
BackgroundWilson, J. B., Blom, E., Cunningham, R., Xiao, Y., Kupfer, G. M., & Jones, N. J. (2010) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2010.04.003 · Cited by 24
“Defective homologous recombination repair of I-SceI induced DNA double strand breaks (DSBs) of an artificial direct-repeat substrate has been reported for both a chicken DT40 fancg mutant and a human FA-G fibroblast cell line [55,59].”
BackgroundThe Caenorhabditis elegans FancD2 ortholog is required for survival following DNA damage
Dequen, F., St-Laurent, J.-F., Gagnon, S., Carreau, M., & Desnoyers, S. (2005) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpc.2005.05.010 · Cited by 22
Activation of the FA pathway mediated by phosphorylation and ubiquitination
Ishiai, M., Sato, K., Tomida, J., Kitao, H., Kurumizaka, H., & Takata, M. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.05.003 · Cited by 20
Paths from DNA damage and signaling to genome rearrangements via homologous recombination
Nickoloff, J. A. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.07.008 · Cited by 23
“and FANC proteins, which predispose to breast and other cancers [145-148].”
BackgroundFanconi anemia D2 protein confers chemoresistance in response to the anticancer agent, irofulven
Wang, Y., Wiltshire, T. D., Senft, J., Wenger, S. L., Reed, E., & Wang, W. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0427 · Cited by 21
Targeting Homologous Recombination Repair in Cancer
Willers, H., Pfäffle, H. N., & Zou, L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-384999-1.10007-1 · Cited by 21
The Fanconi anemia ubiquitin E3 ligase complex as an anti-cancer target
Sharp, M. F., Bythell‐Douglas, R., Deans, A. J., & Crismani, W. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.04.023 · Cited by 20
Liu, J., Majumdar, A., Liu, J., Thompson, L. H., & Seidman, M. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.123844 · Cited by 20
New insights into tumor dormancy: Targeting DNA repair pathways
Evans, E. B. (2015) · World Journal of Clinical Oncology · doi:10.5306/wjco.v6.i5.80 · Cited by 21
Smith, S. N., Fox, J. T., Mejia, M., Ruangpradit, W., Saberi, A., Kim, S., Choi, Y., Oh, S., Wang, Y., Choi, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087203 · Cited by 20
“5GFP) containing twin DR-GFP reporter cassettes [35] that undergo HDR following ISceI-induced DSB formation in the 59 cassette [23].”
MethodInfluentialSu, W., Ho, Y.-C., Wu, C.-K., Hsu, S.-H., Shiu, J.-L., Huang, J.-C., Chang, S., Chiu, W., Hung, J., Liu, T.-L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04223-5 · Cited by 19
Federico, M. B., Campodónico, P. B., Paviolo, N. S., & Gottifredi, V. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.09.004 · Cited by 19
The Fanconi anemia pathway: Insights from somatic cell genetics using DT40 cell line
Takata, M., Ishiai, M., & Kitao, H. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.012 · Cited by 18
Tischler, J. D., Tsuchida, H., Bosire, R., Oda, T. T., Park, A., & Adeyemi, R. O. (2024) · Nature Communications · doi:10.1038/s41467-024-45139-9 · Cited by 17
“To directly examine HR competency at DSBs in the absence of FLIP, we took advantage of U2OS cells expressing a previously repor-ted modi fi ed GFP reporter that fl uoresces green when an I-SceI enzyme-induced DSB is repaired 55 .”
BackgroundChromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors
Gaymes, T. J., Shall, S., Farzaneh, F., & Mufti, G. J. (2008) · Haematologica · doi:10.3324/haematol.13201 · Cited by 17
“The decreased but not absent rad51 foci formation in FA cells suggests that even though FA proteins are intrinsically involved in inter-strand crosslink repair and restart of DNA replication, FA has a mild HR defect as reported by other groups.(15,16) In fact, FA sensitivity to PI could be attributable to cell cycle c…”
BackgroundRole of the Exocyst Complex Component Sec6/8 in Genomic Stability
Torres, M. J., PANDITA, R. K., Kulak, O., Kumar, R., Formstecher, É., Horikoshi, N., Mujoo, K., Hunt, C. R., Zhao, Y., Lum, L., et al. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00768-15 · Cited by 16
“To determine the effect of Sec8 depletion on recruitment at the I-SceI site, cleavage was analyzed by ChIP, using RAD51-, KU80-, and BRCA1-specific antibodies in combination with site-specific PCR primer pairs.”
MethodInfluentialLuo, S., Zhang, Y., Yang, Y., Zhu, S., Liu, W., Zhu, J., Liang, X., Jiang, Z., Sun, S., Hou, X., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.04.695 · Cited by 16
Self-citationFANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons
Kachnic, L. A., Li, L., Fournier, L., Ferraiolo, N., Dahm‐Daphi, J., Borgmann, K., & Willers, H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.030 · Cited by 16
βarrestin-1 regulates DNA repair by acting as an E3-ubiquitin ligase adaptor for 53BP1
Nieto, A., Hara, M. R., Quereda, V., Grant, W. M., Saunders, V. C., Xiao, K., McDonald, P. H., & Duckett, D. R. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0406-6 · Cited by 16
Interstrand crosslinking of homologous repair template DNA enhances gene editing in human cells
Ghasemi, H. I., Bacal, J., Yoon, A. C., Tavasoli, K. U., Cruz, C., Vu, J. T., Gardner, B. M., & Richardson, C. D. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01654-y · Cited by 13
Franken, A., Behrens, B., Reinhardt, F., Yang, L., Rivandi, M., Marass, F., Jaeger, B. A., Krawczyk, N., Cieslik, J., Honisch, E., et al. (2021) · Cancers · doi:10.3390/cancers13236004 · Cited by 14
“Nonsense mutations in FANCA are likely to disrupt function and lead to deficiencies in DNA repair [42].”
BackgroundParvin, J. D., Chiba, N., & Ransburgh, D. J. R. (2011) · Journal of Visualized Experiments · doi:10.3791/2468 · Cited by 14
Fanconi Anemia: Fanconi anemia, breast and embryonal cancer risk revisited
Howlett, N. G. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201860 · Cited by 14
Liu, W., Wang, G., Palovcak, A., Li, Y., Hao, S., Liu, Z., Landgraf, R., Yuan, F., & Zhang, Y. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.02.010 · Cited by 13
Vilcheck, S. K., Ceryak, S. M., O’Brien, T. J., & Patierno, S. R. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.06.009 · Cited by 14
“However, while FA proteins promote HRR, they are apparently not essential to the process [76].”
BackgroundIn vivo analysis of FANCD2 recruitment at meiotic DNA breaks in Caenorhabditis elegans
Germoglio, M., Valenti, A., Gallo, I., Forenza, C., Santonicola, P., Silva, N., & Adamo, A. (2020) · Scientific Reports · doi:10.1038/s41598-019-57096-1 · Cited by 12
Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin
Сергеевна, С. В., Vlasenkova, R., Zhou, Y., Astsaturov, I. A., & Галлямовна, К. Р. (2022) · Molecules · doi:10.3390/molecules27041289 · Cited by 13
“The enrichment of the first two pathways is predictable, considering known mechanisms of platinum cytotoxicity [37,38].”
BackgroundLiang, F., Miller, A. S., Tang, C., Maranon, D. G., Williamson, E. A., Hromas, R., Wiese, C., Zhao, W., Sung, P., & Kupfer, G. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013714 · Cited by 13
“Successful DSB repair leads to GFP expression, the frequency of which is determined by fluorescent cell sorting (28).”
BackgroundBoubakour-Azzouz, I., & Ricchetti, M. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.09.005 · Cited by 13
Phenotyping Genetic Diseases Using an Extension of µ-Scores for Multivariate Data
Morales, J. F., Song, T., Auerbach, A. D., & Wittkowski, K. M. (2008) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1372 · Cited by 13
“Mutations in 13 known genes, FANCA, B, C, D1, D2, E, F, G, I, J, L, M and N (Meetei et al. 2003; Levitus et al. 2004; Levran et al. 2005; Meetei et al. 2005; Reid et al. 2007; Smogorzewska et al. 2007) are known to cause FA through a defect in a BRCA-related DNA repair pathway ( Nakanishi et al. 2005; Wang 2007).”
BackgroundMapping the Genetic Interaction Network of PARP inhibitor ResponsePreprint
Simpson, D., Jia, L., Jing, Y., & Adamson, B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.19.553986 · Cited by 16
Martínez‐Balsalobre, E., Guervilly, J.-H., van der Wijst, J., Pérez‐Oliva, A. B., & Lachaud, C. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101094 · Cited by 14
Boichuk, S., Дунаев, П. Д., Galembikova, A. R., Ганиевич, М. И., & Валерьевна, В. Е. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000637 · Cited by 12
Gravells, P., Hoh, L., Solovieva, S. E., Patil, A. A., Dudziec, E., Rennie, I. G., Sisley, K., & Bryant, H. E. (2013) · Oncogene · doi:10.1038/onc.2012.627 · Cited by 12
Oda, Y., Hidaka, M., & Suzuki, A. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00457 · Cited by 12
Kim, J. T., Zhang, W., Lopategui, J. R., Vail, E., & Balmanoukian, A. S. (2021) · JCO Precision Oncology · doi:10.1200/po.20.00296 · Cited by 12
Casado, J. A., Núñez, M. I., Segovia, J. C., de Almodóvar, J. M. R., & Bueren, J. A. (2005) · Radiation Research · doi:10.1667/rr3395.1 · Cited by 12
Research progress of the Fanconi anemia pathway and premature ovarian insufficiency
Zhao, J., Zhang, Y., Li, W., Yao, M., Liu, C., Zhang, Z., Wang, C., Wang, X., & Meng, K. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad110 · Cited by 11
“FANC proteins involved in the pathway can contribute to the homologous repair of early DNA double-strand breaks (DSBs), which is crucial for maintaining genome stability [21].”
BackgroundHuang, Y., Li, W., Foo, T. K., Ji, J., Wu, B., Tomimatsu, N., Fang, Q., Gao, B., Long, M., Xu, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51557-6 · Cited by 11
“We then utilized U2OS cells harboring the DR-GFP HR reporter 33,34 (Fig.”
How SUMOylation Fine-Tunes the Fanconi Anemia DNA Repair Pathway
Coleman, K. E., & Huang, T. T. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00061 · Cited by 11
The role of Rak in the regulation of stability and function of BRCA1
Kim, J., Ha, G., Campo, L., Denning, M. F., Patel, T. B., Osipo, C., Lin, S., & Breuer, E.-K. Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5717 · Cited by 11
“PCRbased NHEJ/digest assay was carried out as described previously [50].”
MethodThe role of USP 1 autocleavage in DNA interstrand crosslink repair
Kim, M., & Kim, J. M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12060 · Cited by 11
Lu, W.-T., Lemonidis, K., Drayton, R. M., & Nouspikel, T. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17178 · Cited by 10
Caeiro, L. D., Nakata, Y., Borges, R. L., Zha, M., Garcia-Martinez, L., Bañuelos, C. P., Stransky, S., Liu, T., Chan, H. L., Brabson, J., et al. (2024) · Genes & Development · doi:10.1101/gad.351408.123 · Cited by 11
Self-citationPan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines
Dodson, A. E., Shenker, S., Sullivan, P., Nayak, S. U., Middleton, C., McGuire, M. S., Chipumuro, E., Mishina, Y., Tobin, E. R., Cadzow, L., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0316 · Cited by 9
“More observations are needed to determine whether the association between HRD and CUL4B dependency is significant.”
Koptyra, M., Stokłosa, T., Hoser, G., Głodkowska‐Mrówka, E., Seferyńska, I., Klejman, A., Błasiak, J., & Skórski, T. (2011) · Leukemia · doi:10.1038/leu.2011.91 · Cited by 9
Causes and consequences of DNA double-stranded breaks in cardiovascular disease
Marian, A. J. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05131-9 · Cited by 8
“The latter involves over a dozen heterodimeric proteins that participate in ubiquitinoylation of Fanconi anemia complementation group D2 (FANCD2) and homologous recombination (HR) [58].”
Eng, Z. H., Abdullah, M. I., Ng, K. L., Aziz, A. A., Arba’ie, N. H., Rashid, N. M., & Junit, S. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1039494 · Cited by 8
“BRCA2 is a recombination mediator that co-localises with ubiquitinated FANCD2 and facilitates the formation of Rad51 nucleofilaments, linking the FA pathways to homologous recombination (26).”
BackgroundTsuchida, K., & Komatsu, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00915.x · Cited by 8
Disruption of the fanconi anemia pathway in human cancer in the general population
Jacquemont, C. F., & Taniguchi, T. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.12.3658 · Cited by 8
Self-citationFanconi Anemia: Challenges in Diagnosis and Management—A Case Series Report
Eghbali, A., Safdari, S. M., Roozbahani, M. Y., Tavajohi, K., & Hosseini, S. (2024) · Clinical Case Reports · doi:10.1002/ccr3.9583 · Cited by 7
REV7: a small but mighty regulator of genome maintenance and cancer development
Maggs, L. R., & McVey, M. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1516165 · Cited by 7
Palovcak, A., Yuan, F., Verdún, R. E., Luo, L., & Zhang, Y. (2023) · Communications Biology · doi:10.1038/s42003-023-05252-9 · Cited by 6
“In canonical HR that is not coupled to ICLs FA proteins such as FANCA, FANCC and FANCD2 demonstrate a minor role 27 – 30 , yet it is still not clear how and when FA proteins are able to support HR repair.”
InfluentialPaquin, K. L., Mamrak, N. E., Garzon, J. L., Cantres-Velez, J. A., Azzinaro, P. A., Vuono, E. A., Lima, K. E., Camberg, J. L., & Howlett, N. G. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00194-19 · Cited by 7
Cyclin-Dependent Kinase-Mediated Phosphorylation of FANCD2 Promotes Mitotic Fidelity
Cantres-Velez, J. A., Blaize, J. L., Vierra, D. A., Boisvert, R. A., Garzon, J. L., Piraino, B., Tan, W., Deans, A. J., & Howlett, N. G. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00234-21 · Cited by 8
Adibi, A., Tokat, Ü. M., Özgü, E., Aydın, E., Demiray, İ., & Demiray, M. (2023) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231213841 · Cited by 7
TALEN mediated gene editing in a mouse model of Fanconi anemia
Pino-Barrio, M. J., Gimenez, Y. A., Villanueva, M., Hildenbeutel, M., Sánchez‐Domínguez, R., Rodríguez, S., Pujol, R. M., Surrallés, J., Rı́o, P., Cathomen, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-63971-z · Cited by 7
Qin, J., Fan, J., Li, G., Liu, S., Liu, Z., & Yao, W. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02032-5 · Cited by 6
“The Fanconi anemia (FA) pathway is a complex network of functionally diverse proteins that is known for its role in mediating interstrand crosslink (ICL) repair [30].”
BackgroundParvin, J. D., Chiba, N., & Ransburgh, D. J. R. (2011) · Journal of Visualized Experiments · doi:10.3791/2468-v · Cited by 6
Metadata
- Authors
- Nakanishi, K., Yang, Y.-G., Pierce, A. J., Taniguchi, T., Digweed, M., D'Andrea, A. D., Wang, Z.-Q., & Jasin, M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Molecular Biology Program, Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; International Agency for Research on Cancer, 150 Cours Albert Thomas, 69008 Lyon, France; Department of Radiation Oncology, Dana–Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115; and Institut für Humangenetik, Charite-Campus Virchow-Klinikum, Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
- Corresponding author
- Jasin, Maria
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-01-13
- Volume
- 102
- Issue
- 4
- Pages
- 1110-1115
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC545844
- OpenAlex
- W2029164849
- Cited by
- 384
- References
- 42
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 11 · 2023: 10 · 2022: 7 · 2021: 15 · 2020: 12 · 2019: 12 · 2018: 11 · 2017: 24 · 2016: 13 · 2015: 25 · 2014: 22 · 2013: 10 · 2012: 26
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fanconi Anemia Research Fund
- National Institutes of Health
- National Cancer Institute (P01-CA94060, P01CA094060)
- National Institute of General Medical Sciences (R01GM054668, GM54668)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, FANCD2 monoubiquitination, homology-directed repair, DNA double-strand break repair, single-strand annealing, BRCA1, BRCA2, FANCA, FANCG, ATM phosphorylation, DNA repair pathway choice
- MeSH terms
- Cell Line, DNA Repair, Humans, Nuclear Proteins, Recombination, Genetic, Ubiquitin, Fanconi Anemia Complementation Group D2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review